Clinical measures of dysarthria in Friedreich ataxia

Movement Disorders

Volumn 25, Issue 1, 2010, Pages 108-111

  Singh, Arunjot ^a   Epstein, Elizabeth ^a   Myers, Lauren M ^a   Farmer, Jennifer M ^a   Lynch, David R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Ataxia; Balance; Clinical trial; Dysarthria; Sensory neuron

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; DYSARTHRIA; FEMALE; FRIEDREICH ATAXIA; HUMAN; MALE; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM; SPEECH ANALYSIS;

ADULT; CASE-CONTROL STUDIES; DYSARTHRIA; FEMALE; FRIEDREICH ATAXIA; HUMANS; MALE; SPEECH; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 75749115894     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22776     Document Type: Article

References (21)

1. Calon F, Hadj Tahar A, Blanchet PJ, et al. Dopamine-receptor stimulation: biobehavioral and biochemical consequences. Trends Neurosci 2000;23:S92-S100.
2. Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 2005;76:99-125.
3. Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 1990;9:2459-2464.
4. Zhang HT, Li LY, Zou XL, et al. Immunohistochemical distribution of NGF, BDNF, NT-3, and NT-4 in adult rhesus monkey brains. J Histochem Cytochem 2007;55:1-19.
5. Altar CA, Cai N, Bliven T, et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997; 389:856-860.
6. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 1997;17:2295-2313.
7. Belanger N, Gregoire L, Hadj Tahar A, Bedard PJ. Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in Parkinsonian monkeys. Mov Disord 2003;18:1436-1441.
8. Hadj Tahar A, Gregoire L, Darre A, Belanger N, Meltzer L, Bedard PJ. Effect of a selective glutamate antagonist on L-dopainduced dyskinesias in drug-naive parkinsonian monkeys. Neurobiol Dis 2004;15:171-176.
9. Nikam SS, Meltzer LT. NR2B selective NMDA receptor antagonists. Curr Pharm Des 2002;8:845-855.
10. Szabo J, Cowan WM. A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). J Comp Neurol 1984; 222:265-300.
11. Morissette M, Dridi M, Calon F, et al. Prevention of levodopainduced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin. Mov Disord 2006;21:9-17.
12. Samadi P, Gregoire L, Morissette M, et al. mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. Neurobiol Aging 2008;29:1040-1051.
13. Calon F, Rajput AH, Hornykiewicz O, Bedard PJ, Di Paolo T. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease. Neurobiol Dis 2003;14:404-416.
14. Collier TJ, Dung Ling Z, Carvey PM, et al. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced Parkinsonism. Exp Neurol 2005;191(Suppl 1):S60-S67.
15. Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001;411:86-89.
16. Bezard E, Ferry S, Mach U, et al. Attenuation of levodopainduced dyskinesia by normalizing dopamine D3 receptor function. Nat Med 2003;9:762-767.
17. Morissette M, Goulet M, Grondin R, et al. Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies. Eur J Neurosci 1998;10:2565-2573.
18. Fryer HJ, Wolf DH, Knox RJ, et al. Brain-derived neurotrophic factor induces excitotoxic sensitivity in cultured embryonic rat spinal motor neurons through activation of the phosphatidylinositol 3-kinase pathway. J Neurochem 2000;74:582-595.
19. Hu P, Kalb RG. BDNF heightens the sensitivity of motor neurons to excitotoxic insults through activation of TrkB. J Neurochem 2003;84:1421-1430.
20. Mojsilovic-Petrovic J, Jeong GB, Crocker A, et al. Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J Neurosci 2006;26:9250-9263.
21. Foltynie T, Cheeran B, Williams-Gray CH, et al. BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009;80: 141-144.